The distribution of breast cancer stages was: 10.3% stage 0, 41.4% stage I, 37.9% stage II, and 10.3% stage III, and 83% were estrogen receptor positive, 70% were progesterone receptor positive, and 17% were human epidermal growth factor receptor 2 positive. Here, ERBB2 is linked to breast carcinoma.